252
Views
10
CrossRef citations to date
0
Altmetric
Review Article

Growth factor signaling pathways in vascular development and disease

ORCID Icon & ORCID Icon
Pages 53-67 | Received 30 Apr 2019, Accepted 19 Jun 2019, Published online: 08 Jul 2019

References

  • Achen, M. G., M. Jeltsch, E. Kukk, T. Makinen, A. Vitali, A. F. Wilks, K. Alitalo, and S. A. Stacker. 1998. “Vascular Endothelial Growth Factor D (VEGF-D) is a Ligand for the Tyrosine Kinases VEGF Receptor 2 (Flk1) and VEGF Receptor 3 (Flt4).” Proceedings of the National Academy of Sciences of the United States of America 95 (2): 548–553.
  • Armulik, A., G. Genove, and C. Betsholtz. 2011. “Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises.” Developmental Cell 21 (2): 193–215.
  • Aspalter, I. M., E. Gordon, A. Dubrac, A. Ragab, J. Narloch, P. Vizan, I. Geudens, et al. 2015. “Alk1 and Alk5 Inhibition by Nrp1 Controls Vascular Sprouting Downstream of Notch.” Nature Communications 6 (1): 7264.
  • Atri, D., B. Larrivee, A. Eichmann, and M. Simons. 2014. “Endothelial Signaling and the Molecular Basis of Arteriovenous Malformation.” Cellular and Molecular Life Sciences 71 (5): 867–883.
  • Augustin, H. G., and G. Y. Koh. 2017. “Organotypic Vasculature: From Descriptive Heterogeneity to Functional Pathophysiology.” Science 357 (6353): eaal2379.
  • Augustin, H. G., G. Y. Koh, G. Thurston, and K. Alitalo. 2009. “Control of Vascular Morphogenesis and Homeostasis through the Angiopoietin-Tie System.” Nature Reviews Molecular Cell Biology 10 (3): 165–177.
  • Avraamides, C. J., B. Garmy-Susini, and J. A. Varner. 2008. “Integrins in Angiogenesis and Lymphangiogenesis.” Nature Reviews Cancer 8 (8): 604–617.
  • Baeyens, N., C. Bandyopadhyay, B. G. Coon, S. Yun, and M. A. Schwartz. 2016a. “Endothelial Fluid Shear Stress Sensing in Vascular Health and Disease.” The Journal of Clinical Investigation 126 (3): 821–828.
  • Baeyens, N., B. Larrivee, R. Ola, B. Hayward-Piatkowskyi, A. Dubrac, B. Huang, T. D. Ross, et al. 2016b. “Defective Fluid Shear Stress Mechanotransduction Mediates Hereditary Hemorrhagic Telangiectasia.” The Journal of Cell Biology 214 (7): 807–816.
  • Baeyens, N., and M. A. Schwartz. 2016. “Biomechanics of Vascular Mechanosensation and Remodeling.” Molecular Biology of the Cell 27 (1): 7–11.
  • Baffert, F., G. Thurston, M. Rochon-Duck, T. Le, R. Brekken, and D. M. McDonald. 2004. “Age-Related Changes in Vascular Endothelial Growth Factor Dependency and Angiopoietin-1-Induced Plasticity of Adult Blood Vessels.” Circulation Research 94 (7): 984–992.
  • Beets, K., D. Huylebroeck, I. M. Moya, L. Umans, and A. Zwijsen. 2013. “Robustness in Angiogenesis: Notch and BMP Shaping Waves.” Trends in Genetics 29 (3): 140–149.
  • Behjati, S., P. S. Tarpey, H. Sheldon, I. Martincorena, P. Van Loo, G. Gundem, D. C. Wedge, et al. 2014. “Recurrent PTPRB and PLCG1 Mutations in Angiosarcoma.” Nature Genetics 46 (4): 376–379.
  • Benedito, R., S. F. Rocha, M. Woeste, M. Zamykal, F. Radtke, O. Casanovas, A. Duarte, B. Pytowski, and R. H. Adams. 2012. “Notch-Dependent VEGFR3 Upregulation Allows Angiogenesis without VEGF-VEGFR2 Signalling.” Nature 484 (7392): 110–114.
  • Bentley, K., C. A. Franco, A. Philippides, R. Blanco, M. Dierkes, V. Gebala, F. Stanchi, et al. 2014. “The Role of Differential VE-Cadherin Dynamics in Cell Rearrangement during Angiogenesis.” Nature Cell Biology 16 (4): 309–321.
  • Betz, C., A. Lenard, H. G. Belting, and M. Affolter. 2016. “Cell Behaviors and Dynamics during Angiogenesis.” Development 143 (13): 2249–2260.
  • Blanco, R., and H. Gerhardt. 2013. “VEGF and Notch in Tip and Stalk Cell Selection.” Cold Spring Harbor Perspectives in Medicine 3 (1): a006569.
  • Carmeliet, P. 2003. “Angiogenesis in Health and Disease.” Nature Medicine 9 (6): 653–660.
  • Carmeliet, P., V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, et al. 1996. “Abnormal Blood Vessel Development and Lethality in Embryos Lacking a Single VEGF Allele.” Nature 380 (6573): 435–439.
  • Castanares, C., M. Redondo-Horcajo, N. Magan-Marchal, P. ten Dijke, S. Lamas, and F. Rodriguez-Pascual. 2007. “Signaling by ALK5 Mediates TGF-Beta-Induced ET-1 Expression in Endothelial Cells: A Role for Migration and Proliferation.” Journal of Cell Science 120 (7): 1256–1266.
  • Chappell, J. C., S. M. Taylor, N. Ferrara, and V. L. Bautch. 2009. “Local Guidance of Emerging Vessel Sprouts Requires Soluble Flt-1.” Developmental Cell 17 (3): 377–386.
  • Chen, Q., L. Jiang, C. Li, D. Hu, J. W. Bu, D. Cai, and J. L. Du. 2012. “Haemodynamics-Driven Developmental Pruning of Brain Vasculature in Zebrafish.” PLoS Biology 10 (8): e1001374.
  • Cho, C. H., K. E. Kim, J. Byun, H. S. Jang, D. K. Kim, P. Baluk, F. Baffert, et al. 2005. “Long-Term and Sustained COMP-Ang1 Induces Long-Lasting Vascular Enlargement and Enhanced Blood Flow.” Circulation Research 97 (1): 86–94.
  • Choi, H. J., H. Zhang, H. Park, K. S. Choi, H. W. Lee, V. Agrawal, Y. M. Kim, and Y. G. Kwon. 2015. “Yes-Associated Protein Regulates Endothelial Cell Contact-Mediated Expression of Angiopoietin-2.” Nature Communications 6 (1): 6943.
  • Claesson-Welsh, L. 2015. “Vascular Permeability – the Essentials.” Upsala Journal of Medical Sciences 120 (3): 135–143.
  • Daly, C., V. Wong, E. Burova, Y. Wei, S. Zabski, J. Griffiths, K. M. Lai, et al. 2004. “Angiopoietin-1 Modulates Endothelial Cell Function and Gene Expression via the Transcription Factor FKHR (FOXO1).” Genes & Development 18 (9): 1060–1071.
  • De Bock, K., M. Georgiadou, and P. Carmeliet. 2013. “Role of Endothelial Cell Metabolism in Vessel Sprouting.” Cell Metabolism 18 (5): 634–647.
  • De Bock, K., M. Georgiadou, S. Schoors, A. Kuchnio, B. W. Wong, A. R. Cantelmo, A. Quaegebeur, et al. 2013. “Role of PFKFB3-Driven Glycolysis in Vessel Sprouting.” Cell 154 (3): 651–663.
  • del Toro, R., C. Prahst, T. Mathivet, G. Siegfried, J. S. Kaminker, B. Larrivee, C. Breant, et al. 2010. “Identification and Functional Analysis of Endothelial Tip Cell-Enriched Genes.” Blood 116 (19): 4025–4033.
  • Domigan, C. K., C. M. Warren, V. Antanesian, K. Happel, S. Ziyad, S. Lee, A. Krall, et al. 2015. “Autocrine VEGF Maintains Endothelial Survival through Regulation of Metabolism and Autophagy.” Journal of Cell Science 128 (12): 2236–2248.
  • Enge, M., M. Bjarnegard, H. Gerhardt, E. Gustafsson, M. Kalen, N. Asker, H. P. Hammes, M. Shani, R. Fassler, and C. Betsholtz. 2002. “Endothelium-Specific Platelet-Derived Growth Factor-B Ablation Mimics Diabetic Retinopathy.” The EMBO Journal 21 (16): 4307–4316.
  • Eremina, V., J. A. Jefferson, J. Kowalewska, H. Hochster, M. Haas, J. Weisstuch, C. Richardson, et al. 2008. “VEGF Inhibition and Renal Thrombotic Microangiopathy.” New England Journal of Medicine 358 (11): 1129–1136.
  • Felcht, M., R. Luck, A. Schering, P. Seidel, K. Srivastava, J. Hu, A. Bartol, et al. 2012. “Angiopoietin-2 Differentially Regulates Angiogenesis through TIE2 and Integrin Signaling.” Journal of Clinical Investigation 122 (6): 1991–2005.
  • Ferrara, N., and A. P. Adamis. 2016. “Ten Years of Anti-Vascular Endothelial Growth Factor Therapy.” Nature Reviews Drug Discovery 15 (6): 385–403.
  • Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K. S. O’Shea, L. Powell-Braxton, K. J. Hillan, and M. W. Moore. 1996. “Heterozygous Embryonic Lethality Induced by Targeted Inactivation of the VEGF Gene.” Nature 380 (6573): 439–442.
  • Franco, C. A., M. L. Jones, M. O. Bernabeu, I. Geudens, T. Mathivet, A. Rosa, F. M. Lopes, et al. 2015. “Dynamic Endothelial Cell Rearrangements Drive Developmental Vessel Regression.” PLoS Biology 13 (4): e1002125.
  • Frye, M., M. Dierkes, V. Kuppers, M. Vockel, J. Tomm, D. Zeuschner, J. Rossaint, et al. 2015. “Interfering with VE-PTP Stabilizes Endothelial Junctions In Vivo via Tie-2 in the Absence of VE-Cadherin.” The Journal of Experimental Medicine 212 (13): 2267–2287.
  • Gale, N. W., G. Thurston, S. F. Hackett, R. Renard, Q. Wang, J. McClain, C. Martin, et al. 2002. “Angiopoietin-2 is Required for Postnatal Angiogenesis and Lymphatic Patterning, and Only the Latter Role is Rescued by Angiopoietin-1.” Developmental Cell 3 (3): 411–423.
  • Gerber, H. P., K. J. Hillan, A. M. Ryan, J. Kowalski, G. A. Keller, L. Rangell, B. D. Wright, F. Radtke, M. Aguet, and N. Ferrara. 1999. “VEGF is Required for Growth and Survival in Neonatal Mice.” Development 126 (6): 1149–1159.
  • Gerhardt, H., M. Golding, M. Fruttiger, C. Ruhrberg, A. Lundkvist, A. Abramsson, M. Jeltsch, et al. 2003. “VEGF Guides Angiogenic Sprouting Utilizing Endothelial Tip Cell Filopodia.” The Journal of Cell Biology 161 (6): 1163–1177.
  • Giampietro, C., A. Disanza, L. Bravi, M. Barrios-Rodiles, M. Corada, E. Frittoli, C. Savorani, et al. 2015. “The Actin-Binding Protein EPS8 Binds VE-Cadherin and Modulates Yap Localization and Signaling.” The Journal of Cell Biology 211 (6): 1177–1192.
  • Giannotta, M., M. Trani, and E. Dejana. 2013. “VE-Cadherin and Endothelial Adherens Junctions: Active Guardians of Vascular Integrity.” Developmental Cell 26 (5): 441–454.
  • Gordon, E. J., D. Fukuhara, S. Westrom, N. Padhan, E. O. Sjostrom, L. van Meeteren, L. He, et al. 2016. “The Endothelial Adaptor Molecule TSAd is Required for VEGF-Induced Angiogenic Sprouting through Junctional c-Src Activation.” Science Signaling 9 (437): ra72.
  • Goumans, M. J., Z. Liu, and P. ten Dijke. 2009. “TGF-Beta Signaling in Vascular Biology and Dysfunction.” Cell Research 19 (1): 116–127.
  • Goumans, M. J., and P. Ten Dijke. 2018. “TGF-Beta Signaling in Control of Cardiovascular Function.” Cold Spring Harbor Perspectives in Biology 10 (2): a022210.
  • Goumans, M. J., A. Zwijsen, P. Ten Dijke, and S. Bailly. 2018. “Bone Morphogenetic Proteins in Vascular Homeostasis and Disease.” Cold Spring Harbor Perspectives in Biology 10 (2): a031989.
  • Grazia Lampugnani, M., A. Zanetti, M. Corada, T. Takahashi, G. Balconi, F. Breviario, F. Orsenigo, et al. 2003. “Contact Inhibition of VEGF-Induced Proliferation Requires Vascular Endothelial Cadherin, Beta-Catenin, and the Phosphatase DEP-1/CD148.” The Journal of Cell Biology 161 (4):793–804. doi:
  • Guo, D., Q. Jia, H. Y. Song, R. S. Warren, and D. B. Donner. 1995. “Vascular Endothelial Cell Growth Factor Promotes Tyrosine Phosphorylation of Mediators of Signal Transduction that Contain SH2 Domains. Association with Endothelial Cell Proliferation.” Journal of Biological Chemistry 270 (12): 6729–6733.
  • Hackett, S. F., S. Wiegand, G. Yancopoulos, and P. A. Campochiaro. 2002. “Angiopoietin-2 Plays an Important Role in Retinal Angiogenesis.” Journal of Cellular Physiology 192 (2): 182–187.
  • Hakanpaa, L., T. Sipila, V. M. Leppanen, P. Gautam, H. Nurmi, G. Jacquemet, L. Eklund, J. Ivaska, K. Alitalo, and P. Saharinen. 2015. “Endothelial Destabilization by Angiopoietin-2 via Integrin β1 Activation.” Nature Communications 6: 5962.
  • Hammes, H. P., J. Lin, P. Wagner, Y. Feng, F. Vom Hagen, T. Krzizok, O. Renner, G. Breier, M. Brownlee, and U. Deutsch. 2004. “Angiopoietin-2 Causes Pericyte Dropout in the Normal Retina: Evidence for Involvement in Diabetic Retinopathy.” Diabetes 53 (4): 1104–1110.
  • Harrington, L. S., R. C. Sainson, C. K. Williams, J. M. Taylor, W. Shi, J. L. Li, and A. L. Harris. 2008. “Regulation of Multiple Angiogenic Pathways by Dll4 and Notch in Human Umbilical Vein Endothelial Cells.” Microvascular Research 75 (2): 144–154.
  • Hayashi, M., A. Majumdar, X. Li, J. Adler, Z. Sun, S. Vertuani, C. Hellberg, et al. 2013. “VE-PTP Regulates VEGFR2 Activity in Stalk Cells to Establish Endothelial Cell Polarity and Lumen Formation.” Nature Communications 4 (1): 1672.
  • Heinolainen, K., S. Karaman, G. D’Amico, T. Tammela, R. Sormunen, L. Eklund, K. Alitalo, and G. Zarkada. 2017. “VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.” Circulation Research 120 (9): 1414–1425.
  • Hellstrom, M., L. K. Phng, J. J. Hofmann, E. Wallgard, L. Coultas, P. Lindblom, J. Alva, et al. 2007. “Dll4 Signalling through Notch1 Regulates Formation of Tip Cells during Angiogenesis.” Nature 445: 776–780.
  • Hiratsuka, S., O. Minowa, J. Kuno, T. Noda, and M. Shibuya. 1998. “Flt-1 Lacking the Tyrosine Kinase Domain is Sufficient for Normal Development and Angiogenesis in Mice.” Proceedings of the National Academy of Sciences of the United States of America 95 (16): 9349–9354.
  • Honkura, N., M. Richards, B. Lavina, M. Sainz-Jaspeado, C. Betsholtz, and L. Claesson-Welsh. 2018. “Intravital Imaging-Based Analysis Tools for Vessel Identification and Assessment of Concurrent Dynamic Vascular Events.” Nature Communications 9 (1): 2746.
  • Huang, K., C. Andersson, G. M. Roomans, N. Ito, and L. Claesson-Welsh. 2001. “Signaling Properties of VEGF Receptor-1 and -2 Homo- and Heterodimers.” The International Journal of Biochemistry & Cell Biology 33 (4): 315–324.
  • Jakobsson, L., C. A. Franco, K. Bentley, R. T. Collins, B. Ponsioen, I. M. Aspalter, I. Rosewell, et al. 2010. “Endothelial Cells Dynamically Compete for the Tip Cell Position during Angiogenic Sprouting.” Nature Cell Biology 12 (10): 943–953.
  • Jin, Y., L. Muhl, M. Burmakin, Y. Wang, A. C. Duchez, C. Betsholtz, H. M. Arthur, and L. Jakobsson. 2017. “Endoglin Prevents Vascular Malformation by Regulating Flow-Induced Cell Migration and Specification through VEGFR2 Signalling.” Nature Cell Biology 19 (6): 639–652.
  • Joukov, V., K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, E. Kukk, O. Saksela, N. Kalkkinen, and K. Alitalo. 1996. “A Novel Vascular Endothelial Growth Factor, VEGF-C, is a Ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) Receptor Tyrosine Kinases.” The EMBO Journal 15 (2): 290–298.
  • Kamba, T., B. Y. Tam, H. Hashizume, A. Haskell, B. Sennino, M. R. Mancuso, S. M. Norberg, et al. 2006. “VEGF-Dependent Plasticity of Fenestrated Capillaries in the Normal Adult Microvasculature.” American Journal of Physiology-Heart and Circulatory Physiology 290 (2): H560–576.
  • Kato, K., R. Dieguez-Hurtado, D. Y. Park, S. P. Hong, S. Kato-Azuma, S. Adams, M. Stehling, et al. 2018. “Pulmonary Pericytes Regulate Lung Morphogenesis.” Nature Communications 9 (1): 2448.
  • Kendall, R. L., and K. A. Thomas. 1993. “Inhibition of Vascular Endothelial Cell Growth Factor Activity by an Endogenously Encoded Soluble Receptor.” Proceedings of the National Academy of Sciences of the United States of America 90 (22): 10705–10709.
  • Kim, M., B. Allen, E. A. Korhonen, M. Nitschke, H. W. Yang, P. Baluk, P. Saharinen, et al. 2016. “Opposing Actions of Angiopoietin-2 on Tie2 Signaling and FOXO1 Activation.” The Journal of Clinical Investigation 126 (9): 3511–3525.
  • Kim, Y. H., J. Choi, M. J. Yang, S. P. Hong, C. K. Lee, Y. Kubota, D. S. Lim, and G. Y. Koh. 2019. “A MST1-FOXO1 Cascade Establishes Endothelial Tip Cell Polarity and Facilitates Sprouting Angiogenesis.” Nature Communications 10 (1): 838.
  • Kim, J., Y. H. Kim, J. Kim, D. Y. Park, H. Bae, D. H. Lee, K. H. Kim, et al. 2017a. “Yap/TAZ Regulates Sprouting Angiogenesis and Vascular Barrier Maturation.” Journal of Clinical Investigation 127 (9): 3441–3461.
  • Kim, J., D. Y. Park, H. Bae, D. Y. Park, D. Kim, C. K. Lee, S. Song, et al. 2017b. “Impaired Angiopoietin/Tie2 Signaling Compromises Schlemm’s Canal Integrity and Induces Glaucoma.” Journal of Clinical Investigation 127 (10): 3877–3896.
  • Kochhan, E., A. Lenard, E. Ellertsdottir, L. Herwig, M. Affolter, H. G. Belting, and A. F. Siekmann. 2013. “Blood Flow Changes Coincide with Cellular Rearrangements during Blood Vessel Pruning in Zebrafish Embryos.” PLoS One 8 (10): e75060.
  • Korhonen, E. A., A. Lampinen, H. Giri, A. Anisimov, M. Kim, B. Allen, S. Fang, et al. 2016. “Tie1 Controls Angiopoietin Function in Vascular Remodeling and Inflammation.” Journal of Clinical Investigation 126 (9): 3495–3510.
  • Korn, C., and H. G. Augustin. 2015. “Mechanisms of Vessel Pruning and Regression.” Developmental Cell 34 (1): 5–17.
  • Kume, T. 2012. “Ligand-Dependent Notch Signaling in Vascular Formation.” Advances in Experimental Medicine and Biology 727: 210–222.
  • Kutys, M. L., and C. S. Chen. 2016. “Forces and Mechanotransduction in 3D Vascular Biology.” Current Opinion in Cell Biology 42: 73–79.
  • Lamar, J. M., V. Motilal Nehru, and G. Weinberg. 2018. “Epithelioid Hemangioendothelioma as a Model of Yap/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma.” Cancers (Basel) 10 (7): 229.
  • Larrivee, B., C. Prahst, E. Gordon, R. del Toro, T. Mathivet, A. Duarte, M. Simons, and A. Eichmann. 2012. “ALK1 Signaling Inhibits Angiogenesis by Cooperating with the Notch Pathway.” Developmental Cell 22: 489–500.
  • Lebrin, F., M. J. Goumans, L. Jonker, R. L. Carvalho, G. Valdimarsdottir, M. Thorikay, C. Mummery, H. M. Arthur, and P. ten Dijke. 2004. “Endoglin Promotes Endothelial Cell Proliferation and TGF-Beta/ALK1 Signal Transduction.” The EMBO Journal 23 (20): 4018–4028.
  • Lee, S., T. T. Chen, C. L. Barber, M. C. Jordan, J. Murdock, S. Desai, N. Ferrara, A. Nagy, K. P. Roos, and M. L. Iruela-Arispe. 2007. “Autocrine VEGF Signaling Is Required for Vascular Homeostasis.” Cell 130 (4): 691–703.
  • Lee, H. W., D. C. Chong, R. Ola, W. P. Dunworth, S. Meadows, J. Ka, V. M. Kaartinen, et al. 2017. “Alk2/ACVR1 and Alk3/BMPR1A Provide Essential Function for Bone Morphogenetic Protein-Induced Retinal Angiogenesis.” Arteriosclerosis, Thrombosis, and Vascular Biology 37 (4): 657–663.
  • Lenard, A., S. Daetwyler, C. Betz, E. Ellertsdottir, H. G. Belting, J. Huisken, and M. Affolter. 2015. “Endothelial Cell Self-Fusion during Vascular Pruning.” PLoS Biology 13 (4): e1002126.
  • Leung, D. W., G. Cachianes, W. J. Kuang, D. V. Goeddel, and N. Ferrara. 1989. “Vascular Endothelial Growth Factor is a Secreted Angiogenic Mitogen.” Science 246 (4935): 1306–1309.
  • Liu, Y., J. Shen, S. D. Fortmann, J. Wang, D. Vestweber, and P. A. Campochiaro. 2017. “Reversible Retinal Vessel Closure from VEGF-Induced Leukocyte Plugging.” JCI Insight 2 (18): pii: 95530.
  • Liu, Z. J., T. Shirakawa, Y. Li, A. Soma, M. Oka, G. P. Dotto, R. M. Fairman, O. C. Velazquez, and M. Herlyn. 2003. “Regulation of Notch1 and Dll4 by Vascular Endothelial Growth Factor in Arterial Endothelial Cells: Implications for Modulating Arteriogenesis and Angiogenesis.” Molecular and Cellular Biology 23 (1): 14–25.
  • Liu, Z., A. Turkoz, E. N. Jackson, J. C. Corbo, J. A. Engelbach, J. R. Garbow, D. R. Piwnica-Worms, and R. Kopan. 2011. “Notch1 Loss of Heterozygosity Causes Vascular Tumors and Lethal Hemorrhage in Mice.” Journal of Clinical Investigation 121 (2): 800–808.
  • Lobov, I. B., R. A. Renard, N. Papadopoulos, N. W. Gale, G. Thurston, G. D. Yancopoulos, and S. J. Wiegand. 2007. “Delta-like Ligand 4 (Dll4) is Induced by VEGF as a Negative Regulator of Angiogenic Sprouting.” Proceedings of the National Academy of Sciences of the United States of America 104 (9): 3219–3224.
  • Maglione, D., V. Guerriero, G. Viglietto, P. Delli-Bovi, and M. G. Persico. 1991. “Isolation of a Human Placenta cDNA Coding for a Protein Related to the Vascular Permeability Factor.” Proceedings of the National Academy of Sciences of the United States of America 88 (20): 9267–9271.
  • Maisonpierre, P. C., C. Suri, P. F. Jones, S. Bartunkova, S. J. Wiegand, C. Radziejewski, D. Compton, et al. 1997. “Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts In Vivo Angiogenesis.” Science (New York, N.Y.) 277 (5322): 55–60.
  • Mandriota, S. J., and M. S. Pepper. 1998. “Regulation of Angiopoietin-2 mRNA Levels in Bovine Microvascular Endothelial Cells by Cytokines and Hypoxia.” Circulation Research 83 (8): 852–859.
  • Miller, J. W., J. Le Couter, E. C. Strauss, and N. Ferrara. 2013. “Vascular Endothelial Growth Factor a in Intraocular Vascular Disease.” Ophthalmology 120 (1): 106–114.
  • Morini, M. F., C. Giampietro, M. Corada, F. Pisati, E. Lavarone, S. I. Cunha, L. L. Conze, et al. 2018. “VE-Cadherin-Mediated Epigenetic Regulation of Endothelial Gene Expression.” Circulation Research 122 (2): 231–245.
  • Moya, I. M., L. Umans, E. Maas, P. N. Pereira, K. Beets, A. Francis, W. Sents, et al. 2012. “Stalk Cell Phenotype Depends on Integration of Notch and Smad1/5 Signaling Cascades.” Developmental Cell 22 (3):501–514.
  • Mueller, S. B., and C. D. Kontos. 2016. “Tie1: An Orphan Receptor Provides Context for Angiopoietin-2/Tie2 Signaling.” Journal of Clinical Investigation 126 (9): 3188–3191.
  • Murali, R., R. Chandramohan, I. Moller, S. L. Scholz, M. Berger, K. Huberman, A. Viale, et al. 2015. “Targeted Massively Parallel Sequencing of Angiosarcomas Reveals Frequent Activation of the Mitogen Activated Protein Kinase Pathway.” Oncotarget 6 (34): 36041–36052.
  • Neto, F., A. Klaus-Bergmann, Y. T. Ong, S. Alt, A. C. Vion, A. Szymborska, J. R. Carvalho, et al. 2018. “Yap and TAZ Regulate Adherens Junction Dynamics and Endothelial Cell Distribution during Vascular Development.” eLife 7: pii: e31037.
  • Nguyen, H. L., L. M. Boon, and M. Vikkula. 2017. “Vascular Anomalies Caused by Abnormal Signaling within Endothelial Cells: Targets for Novel Therapies.” Seminars in Interventional Radiology 34 (03): 233–238.
  • Oh, H., H. Takagi, K. Suzuma, A. Otani, M. Matsumura, and Y. Honda. 1999. “Hypoxia and Vascular Endothelial Growth Factor Selectively up-Regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells.” Journal of Biological Chemistry 274 (22): 15732–15739.
  • Ola, R., A. Dubrac, J. Han, F. Zhang, J. S. Fang, B. Larrivee, M. Lee, et al. 2016. “PI3 Kinase Inhibition Improves Vascular Malformations in Mouse Models of Hereditary Haemorrhagic Telangiectasia.” Nature Communications 7 (1): 13650.
  • Ola, R., S. H. Kunzel, F. Zhang, G. Genet, R. Chakraborty, L. Pibouin-Fragner, K. Martin, W. Sessa, A. Dubrac, and A. Eichmann. 2018. “SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.” Circulation 138 (21): 2379–2394.
  • Olofsson, B., K. Pajusola, A. Kaipainen, G. von Euler, V. Joukov, O. Saksela, A. Orpana, R. F. Pettersson, K. Alitalo, and U. Eriksson. 1996. “Vascular Endothelial Growth Factor B, a Novel Growth Factor for Endothelial Cells.” Proceedings of the National Academy of Sciences of the United States of America 93 (6): 2576–2581.
  • Paik, J. H., R. Kollipara, G. Chu, H. Ji, Y. Xiao, Z. Ding, L. Miao, et al. 2007. “FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis.” Cell 128 (2): 309–323.
  • Pajusola, K., O. Aprelikova, J. Korhonen, A. Kaipainen, L. Pertovaara, R. Alitalo, and K. Alitalo. 1992. “FLT4 Receptor Tyrosine Kinase Contains Seven Immunoglobulin-like Loops and Is Expressed in Multiple Human Tissues and Cell Lines.” Cancer Research 52: 5738–5743.
  • Park, D. Y., J. Lee, J. Kim, K. Kim, S. Hong, S. Han, Y. Kubota, et al. 2017. “Plastic Roles of Pericytes in the Blood-Retinal Barrier.” Nature Communications 8: 15296.
  • Parker, M. W., P. Xu, X. Li, and C. W. Vander Kooi. 2012. “Structural Basis for Selective Vascular Endothelial Growth factor-A (VEGF-A) Binding to Neuropilin-1.” Journal of Biological Chemistry 287 (14): 11082–11089.
  • Parra-Bonilla, G., D. F. Alvarez, A. B. Al-Mehdi, M. Alexeyev, and T. Stevens. 2010. “Critical Role for Lactate Dehydrogenase a in Aerobic Glycolysis That Sustains Pulmonary Microvascular Endothelial Cell Proliferation.” American Journal of Physiology Lung Cellular and Molecular Physiology 299 (4): L513–522.
  • Poduri, A., A. H. Chang, B. Raftrey, S. Rhee, M. Van, and K. Red-Horse. 2017. “Endothelial Cells Respond to the Direction of Mechanical Stimuli through SMAD Signaling to Regulate Coronary Artery Size.” Development 144 (18): 3241–3252.
  • Potente, M., and P. Carmeliet. 2017. “The Link between Angiogenesis and Endothelial Metabolism.” Annual Review of Physiology 79: 43–66.
  • Potente, M., and T. Makinen. 2017. “Vascular Heterogeneity and Specialization in Development and Disease.” Nature Reviews Molecular Cell Biology 18 (8): 477–494.
  • Reeson, P., K. Choi, and C. E. Brown. 2018. “VEGF Signaling Regulates the Fate of Obstructed Capillaries in Mouse Cortex.” eLife 7: pii: e33670.
  • Rochon, E. R., P. G. Menon, and B. L. Roman. 2016. “Alk1 Controls Arterial Endothelial Cell Migration in Lumenized Vessels.” Development 143 (14): 2593–2602.
  • Roman, B. L., and A. P. Hinck. 2017. “ALK1 Signaling in Development and Disease: New Paradigms.” Cellular and Molecular Life Sciences 74 (24): 4539–4560.
  • Ruhrberg, C., H. Gerhardt, M. Golding, R. Watson, S. Ioannidou, H. Fujisawa, C. Betsholtz, and D. T. Shima. 2002. “Spatially Restricted Patterning Cues Provided by Heparin-Binding VEGF-A Control Blood Vessel Branching Morphogenesis.” Genes & Development 16 (20): 2684–2698.
  • Saharinen, P., L. Eklund, and K. Alitalo. 2017. “Therapeutic Targeting of the Angiopoietin-TIE Pathway.” Nature Reviews Drug Discovery 16 (9): 635–661.
  • Saharinen, P., L. Eklund, J. Miettinen, R. Wirkkala, A. Anisimov, M. Winderlich, A. Nottebaum, et al. 2008. “Angiopoietins Assemble Distinct Tie2 Signalling Complexes in Endothelial Cell-Cell and Cell-Matrix Contacts.” Nature Cell Biology 10 (5): 527–537.
  • Sakabe, M., J. Fan, Y. Odaka, N. Liu, A. Hassan, X. Duan, P. Stump, et al. 2017. “Yap/TAZ-CDC42 Signaling Regulates Vascular Tip Cell Migration.” Proceedings of the National Academy of Sciences of the United States of America 114 (41): 10918–10923.
  • Savant, S., S. La Porta, A. Budnik, K. Busch, J. Hu, N. Tisch, C. Korn, et al. 2015. “The Orphan Receptor Tie1 Controls Angiogenesis and Vascular Remodeling by Differentially Regulating Tie2 in Tip and Stalk Cells.” Cell Reports 12: 1761–1773.
  • Schimmel, L., and E. Gordon. 2018. “The Precise Molecular Signals That Control Endothelial Cell-Cell Adhesion within the Vessel Wall.” Biochemical Society Transactions 46 (6): 1673–1680.
  • Shalaby, F., J. Rossant, T. P. Yamaguchi, M. Gertsenstein, X. F. Wu, M. L. Breitman, and A. C. Schuh. 1995. “Failure of Blood-Island Formation and Vasculogenesis in Flk-1-Deficient Mice.” Nature 376 (6535): 62–66.
  • Shibuya, M., S. Yamaguchi, A. Yamane, T. Ikeda, A. Tojo, H. Matsushime, and M. Sato. 1990. “Nucleotide Sequence and Expression of a Novel Human Receptor-Type Tyrosine Kinase Gene (Flt) Closely Related to the Fms Family.” Oncogene 5: 519–524.
  • Siekmann, A. F., M. Affolter, and H. G. Belting. 2013. “The Tip Cell Concept 10 Years after: New Players Tune in for a Common Theme.” Experimental Cell Research 319 (9): 1255–1263.
  • Simons, M., E. Gordon, and L. Claesson-Welsh. 2016. “Mechanisms and Regulation of Endothelial VEGF Receptor Signalling.” Nature Reviews Molecular Cell Biology 17 (10): 611–625.
  • Soker, S., S. Takashima, H. Q. Miao, G. Neufeld, and M. Klagsbrun. 1998. “Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor.” Cell 92 (6): 735–745.
  • Souma, T., S. W. Tompson, B. R. Thomson, O. M. Siggs, K. Kizhatil, S. Yamaguchi, L. Feng, et al. 2016. “Angiopoietin Receptor TEK Mutations Underlie Primary Congenital Glaucoma with Variable Expressivity.” Journal of Clinical Investigation 126 (7): 2575–2587.
  • Stitt, A. W., T. M. Curtis, M. Chen, R. J. Medina, G. J. McKay, A. Jenkins, T. A. Gardiner, et al. 2016. “The Progress in Understanding and Treatment of Diabetic Retinopathy.” Progress in Retinal and Eye Research 51: 156–186.
  • Strasser, G. A., J. S. Kaminker, and M. Tessier-Lavigne. 2010. “Microarray Analysis of Retinal Endothelial Tip Cells Identifies CXCR4 as a Mediator of Tip Cell Morphology and Branching.” Blood 115 (24): 5102–5110.
  • Suchting, S., C. Freitas, F. Le Noble, R. Benedito, C. Breant, A. Duarte, and A. Eichmann. 2007. “The Notch Ligand Delta-like 4 Negatively Regulates Endothelial Tip Cell Formation and Vessel Branching.” Proceedings of the National Academy of Sciences of the United States of America 104 (9): 3225–3230.
  • Sugden, W. W., R. Meissner, T. Aegerter-Wilmsen, R. Tsaryk, E. V. Leonard, J. Bussmann, M. J. Hamm, et al. 2017. “Endoglin Controls Blood Vessel Diameter through Endothelial Cell Shape Changes in Response to Haemodynamic Cues.” Nature Cell Biology 19 (6): 653–665.
  • Sun, Z., X. Li, S. Massena, S. Kutschera, N. Padhan, L. Gualandi, V. Sundvold-Gjerstad, et al. 2012. “VEGFR2 Induces c-Src Signaling and Vascular Permeability In Vivo via the Adaptor Protein TSAd.” The Journal of Experimental Medicine 209 (7): 1363–1377.
  • Tammela, T., G. Zarkada, H. Nurmi, L. Jakobsson, K. Heinolainen, D. Tvorogov, W. Zheng, et al. 2011. “VEGFR-3 Controls Tip to Stalk Conversion at Vessel Fusion Sites by Reinforcing Notch Signalling.” Nature Cell Biology 13 (10): 1202–1213.
  • Tammela, T., G. Zarkada, E. Wallgard, A. Murtomaki, S. Suchting, M. Wirzenius, M. Waltari, et al. 2008. “Blocking VEGFR-3 Suppresses Angiogenic Sprouting and Vascular Network Formation.” Nature 454 (7204): 656–660.
  • Tanas, M. R., S. Ma, F. O. Jadaan, C. K. Ng, B. Weigelt, J. S. Reis-Filho, and B. P. Rubin. 2016. “Mechanism of Action of a WWTR1(TAZ)-CAMTA1 Fusion Oncoprotein.” Oncogene 35 (7): 929–938.
  • Terman, B. I., M. E. Carrion, E. Kovacs, B. A. Rasmussen, R. L. Eddy, and T. B. Shows. 1991. “Identification of a New Endothelial Cell Growth Factor Receptor Tyrosine Kinase.” Oncogene 6: 1677–1683.
  • Thomson, B. R., S. Heinen, M. Jeansson, A. K. Ghosh, A. Fatima, H. K. Sung, T. Onay, et al. 2014. “A Lymphatic Defect Causes Ocular Hypertension and Glaucoma in Mice.” Journal of Clinical Investigation 124 (10): 4320–4324.
  • Thurston, G., Q. Wang, F. Baffert, J. Rudge, N. Papadopoulos, G. Jean, D. S. Wiegand, G. D. Yancopoulos, and D. M. McDonald. 2005. “Angiopoietin 1 Causes Vessel Enlargement, without Angiogenic Sprouting, during a Critical Developmental Period.” Development 132 (14): 3317–3326.
  • Totaro, A., T. Panciera, and S. Piccolo. 2018. “Yap/TAZ Upstream Signals and Downstream Responses.” Nature Cell Biology 20 (8): 888–899.
  • Tual-Chalot, S., M. Mahmoud, K. R. Allinson, R. E. Redgrave, Z. Zhai, S. P. Oh, M. Fruttiger, and H. M. Arthur. 2014. “Endothelial Depletion of Acvrl1 in Mice Leads to Arteriovenous Malformations Associated with Reduced Endoglin Expression.” PLoS One 9 (6): e98646.
  • Uemura, A., M. Ogawa, M. Hirashima, T. Fujiwara, S. Koyama, H. Takagi, Y. Honda, S. J. Wiegand, G. D. Yancopoulos, and S. Nishikawa. 2002. “Recombinant Angiopoietin-1 Restores Higher-Order Architecture of Growing Blood Vessels in Mice in the Absence of Mural Cells.” Journal of Clinical Investigation 110 (11): 1619–1628.
  • Upton, P. D., R. J. Davies, R. C. Trembath, and N. W. Morrell. 2009. “Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells.” Journal of Biological Chemistry 284 (23): 15794–15804.
  • Vaahtomeri, K., S. Karaman, T. Makinen, and K. Alitalo. 2017. “Lymphangiogenesis Guidance by Paracrine and Pericellular Factors.” Genes & Development 31 (16): 1615–1634.
  • Wang, X., A. Freire Valls, G. Schermann, Y. Shen, I. M. Moya, L. Castro, S. Urban, et al. 2017. “Yap/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis.” Developmental Cell 42: 462–478.e7.
  • Wiley, D. M., J. D. Kim, J. Hao, C. C. Hong, V. L. Bautch, and S. W. Jin. 2011. “Distinct Signalling Pathways Regulate Sprouting Angiogenesis from the Dorsal Aorta and the Axial Vein.” Nature Cell Biology 13 (6): 686–692.
  • Wilhelm, K., K. Happel, G. Eelen, S. Schoors, M. F. Oellerich, R. Lim, B. Zimmermann, et al. 2016. “FOXO1 Couples Metabolic Activity and Growth State in the Vascular Endothelium.” Nature 529 (7585): 216–220.
  • Xu, C., S. S. Hasan, I. Schmidt, S. F. Rocha, M. E. Pitulescu, J. Bussmann, D. Meyen, E. Raz, R. H. Adams, and A. F. Siekmann. 2014. “Arteries Are Formed by Vein-Derived Endothelial Tip Cells.” Nature Communications 5 (1): 5758.
  • Yan, M., C. A. Callahan, J. C. Beyer, K. P. Allamneni, G. Zhang, J. B. Ridgway, K. Niessen, and G. D. Plowman. 2010. “Chronic DLL4 Blockade Induces Vascular Neoplasms.” Nature 463 (7282): E6–E7.
  • Yang, X., L. Liaw, I. Prudovsky, P. C. Brooks, C. Vary, L. Oxburgh, and R. Friesel. 2015. “Fibroblast Growth Factor Signaling in the Vasculature.” Current Atherosclerosis Reports 17 (6): 509.
  • Yang, Y., Y. Zhang, Z. Cao, H. Ji, X. Yang, H. Iwamoto, E. Wahlberg, T. Lanne, B. Sun, and Y. Cao. 2013. “Anti-VEGF- and anti-VEGF Receptor-Induced Vascular Alteration in Mouse Healthy Tissues.” Proceedings of the National Academy of Sciences of the United States of America 110 (29): 12018–12023.
  • Yeh, W. L., C. J. Lin, and W. M. Fu. 2008. “Enhancement of Glucose Transporter Expression of Brain Endothelial Cells by Vascular Endothelial Growth Factor Derived from Glioma Exposed to Hypoxia.” Molecular Pharmacology 73 (1): 170–177.
  • Yu, P., K. Wilhelm, A. Dubrac, J. K. Tung, T. C. Alves, J. S. Fang, Y. Xie, et al. 2017. “FGF-Dependent Metabolic Control of Vascular Development.” Nature 545 (7653): 224–228.
  • Zarkada, G., K. Heinolainen, T. Makinen, Y. Kubota, and K. Alitalo. 2015. “VEGFR3 Does Not Sustain Retinal Angiogenesis without VEGFR2.” Proceedings of the National Academy of Sciences of the United States of America 112 (3): 761–766.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.